bimagrumab semaglutide combination trial Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization Next-Gen Obesity Trials: Redefining Efficacy,

Bibcode:2002PNAS...99.2356L

The STEP-2 trial demonstrated that semaglutide 2.4 mg reduced HbA1c by 1.6 percentage points in adults with obesity and type 2 diabetes, alongside 9.6% body weight loss [4]

The disease is also believed to have affected other ethnic groups, but was misdiagnosed due to the doctors' ignorance (236, 237)

Whenever youre activating something in the brain, we can expect that the brain and the GI tract may respond with nausea. GLP-1 medications also work in the gut by slowing down the digestion process, so food is in the stomach for a longer period of time

Further research is needed to establish whether Ipamorelin administration influences sleep architecture, recovery processes, or subjective sleep quality in controlled settings